Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata

Detalhes bibliográficos
Autor(a) principal: Rezende, Laura de Castro
Data de Publicação: 2020
Tipo de documento: Trabalho de conclusão de curso
Idioma: por
Título da fonte: Repositório Institucional da UFU
Texto Completo: https://repositorio.ufu.br/handle/123456789/30846
Resumo: Prostate cancer (PCa) is the second most common tumor in men and the second leading cause of death from cancer in this group. The discovery of biomarkers can contribute to early diagnosis, increasing the chances of cure and directing new therapeutic strategies. Genetic polymorphisms are essential in defining risk groups, whether related to therapeutic resistance or to the development of chronic diseases such as cancer. Toll-like receptors (TLRs) are innate immunity receptors that activate pro-inflammatory signaling pathways in response to intracellular damage or patterns associated with pathogens. The TLR4 receptor recognizes lipopolysaccharides, but is also related to the development of tumors. Our aim was to evaluate the Thr399Ile polymorphism of the TLR4 gene and its association with the risk of PCa occurrence. Twenty-nine patients with PCa and 22 with benign prostatic hyperplasia (BPH), genotyped by PCR-RFLP, were analyzed using the enzyme Hinf I. The genotypes found were normal homozygous-CC (16 with PCa and 11 with BPH), mutant homozygous-TT (10 with PCa and 10 with BPH) and heterorygous-CT (3 with PCa and 1 with BPH). However, in both groups, the genotypes were not in Hardy-Weinberg equilibrium. In addition, genotypic frequencies were not statistically different between individuals with PCa and BPH without correlation with clinical and anatomopathological data such as PSA (Prostatic-Specific Antigen), Gleason score and TNM. For the allelic distribution, the C allele was more frequent in patients with PCa, however without statistical significance. Studies with a larger number of participants and functional tests are needed to elucidate the role of this polymorphism in PCa.
id UFU_a19a2bc3d69a5a09764694caa491660c
oai_identifier_str oai:repositorio.ufu.br:123456789/30846
network_acronym_str UFU
network_name_str Repositório Institucional da UFU
repository_id_str
spelling Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstataAssociation between the TLR-4 gene Thr399Ile polymorphism and susceptibility to prostate cancerCâncer de PróstataPolimorfismoBiomarcadorSNPTLR4Prostate cancerPolymorphismBiomarkerCNPQ::CIENCIAS DA SAUDEProstate cancer (PCa) is the second most common tumor in men and the second leading cause of death from cancer in this group. The discovery of biomarkers can contribute to early diagnosis, increasing the chances of cure and directing new therapeutic strategies. Genetic polymorphisms are essential in defining risk groups, whether related to therapeutic resistance or to the development of chronic diseases such as cancer. Toll-like receptors (TLRs) are innate immunity receptors that activate pro-inflammatory signaling pathways in response to intracellular damage or patterns associated with pathogens. The TLR4 receptor recognizes lipopolysaccharides, but is also related to the development of tumors. Our aim was to evaluate the Thr399Ile polymorphism of the TLR4 gene and its association with the risk of PCa occurrence. Twenty-nine patients with PCa and 22 with benign prostatic hyperplasia (BPH), genotyped by PCR-RFLP, were analyzed using the enzyme Hinf I. The genotypes found were normal homozygous-CC (16 with PCa and 11 with BPH), mutant homozygous-TT (10 with PCa and 10 with BPH) and heterorygous-CT (3 with PCa and 1 with BPH). However, in both groups, the genotypes were not in Hardy-Weinberg equilibrium. In addition, genotypic frequencies were not statistically different between individuals with PCa and BPH without correlation with clinical and anatomopathological data such as PSA (Prostatic-Specific Antigen), Gleason score and TNM. For the allelic distribution, the C allele was more frequent in patients with PCa, however without statistical significance. Studies with a larger number of participants and functional tests are needed to elucidate the role of this polymorphism in PCa.Pesquisa sem auxílio de agências de fomentoTrabalho de Conclusão de Curso (Graduação)O câncer de próstata (CaP) é o segundo tumor mais frequente em homens e a segunda maior causa de morte pela doença. A descoberta de biomarcadores pode contribuir para o diagnóstico precoce, ampliando as chances de cura e direcionando novas estratégias terapêuticas. Polimorfismos genéticos são essenciais na definição de grupos de risco, sejam estes relacionados à resistência terapêutica ou ao desnvolvimento de doenças graves como o câncer. Os receptores Toll-like (TLRs) são receptores da imunidade inata que ativam vias de sinalização pró-inflamatórias em resposta a danos intracelulares ou a padrões associados à patógenos. O receptor TLR4 é capaz de reconhecer lipopolissacarídeos, mas também relacionado ao desenvolvimento de tumores. Nossa proposta foi avaliar o polimorfismo Thr399Ile do gene TLR4 e sua associação com o risco de ocorrência do CaP. Foram analisados 29 pacientes com CaP e 22 com hiperplasia prostática benigna (HPB), genotipados por PCR-RFLP, utilizando a enzima Hinf I. Os genótipos encontrados foram CC-homozigotos normais (16 com CaP e 11 com HPB), TT-homozigotos mutantes (10 com CaP e 10 com HPB) e CT-heterozigotos (3 com CaP e 1 com HPB). Contudo, em ambos os grupos de estudo, os genótipos não se encontravam em equilíbrio de Hardy-Weinberg. Além disso, as frequencias genotípicas não diferiram estatisticamente entre os indivíduos com CaP e HPB sem correlação com dados clínicos e anatomopatológicos como PSA (Antígeno Prostático Específico), escore de Gleason e TNM. Quanto à distribuição alélica, o alelo C foi mais frequente nos pacientes com CaP, contudo sem significância estatística. Estudos com um maior número de participantes e ensaios funcionais são necessários para elucidar o papel dessa variante no CaP.Universidade Federal de UberlândiaBrasilBiotecnologiaAraújo, Thaise Gonçalves dehttp://lattes.cnpq.br/3348615812243880Teixeira, Terezinha Aparecidahttp://lattes.cnpq.br/7904376013279747Oliveira, Luciana Almeida dehttp://lattes.cnpq.br/8001872702729412Rezende, Laura de Castro2020-12-28T14:46:16Z2020-12-28T14:46:16Z2020-12-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisapplication/pdfREZENDE, Laura de Castro. Associação entre o polimorfismo Thr399Ile do gene TLR4 e a susceptibilidade ao câncer de próstata. 2020. 41f. Trabalho de Conclusão de Curso (Graduação em Biotecnologia) - Universidade Federal de Uberlândia, 2020.https://repositorio.ufu.br/handle/123456789/30846porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFUinstname:Universidade Federal de Uberlândia (UFU)instacron:UFU2020-12-29T06:16:07Zoai:repositorio.ufu.br:123456789/30846Repositório InstitucionalONGhttp://repositorio.ufu.br/oai/requestdiinf@dirbi.ufu.bropendoar:2020-12-29T06:16:07Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU)false
dc.title.none.fl_str_mv Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
Association between the TLR-4 gene Thr399Ile polymorphism and susceptibility to prostate cancer
title Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
spellingShingle Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
Rezende, Laura de Castro
Câncer de Próstata
Polimorfismo
Biomarcador
SNP
TLR4
Prostate cancer
Polymorphism
Biomarker
CNPQ::CIENCIAS DA SAUDE
title_short Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
title_full Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
title_fullStr Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
title_full_unstemmed Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
title_sort Associação entre o polimorfismo Thr399Ile do gene TLR-4 e a susceptibilidade ao câncer de próstata
author Rezende, Laura de Castro
author_facet Rezende, Laura de Castro
author_role author
dc.contributor.none.fl_str_mv Araújo, Thaise Gonçalves de
http://lattes.cnpq.br/3348615812243880
Teixeira, Terezinha Aparecida
http://lattes.cnpq.br/7904376013279747
Oliveira, Luciana Almeida de
http://lattes.cnpq.br/8001872702729412
dc.contributor.author.fl_str_mv Rezende, Laura de Castro
dc.subject.por.fl_str_mv Câncer de Próstata
Polimorfismo
Biomarcador
SNP
TLR4
Prostate cancer
Polymorphism
Biomarker
CNPQ::CIENCIAS DA SAUDE
topic Câncer de Próstata
Polimorfismo
Biomarcador
SNP
TLR4
Prostate cancer
Polymorphism
Biomarker
CNPQ::CIENCIAS DA SAUDE
description Prostate cancer (PCa) is the second most common tumor in men and the second leading cause of death from cancer in this group. The discovery of biomarkers can contribute to early diagnosis, increasing the chances of cure and directing new therapeutic strategies. Genetic polymorphisms are essential in defining risk groups, whether related to therapeutic resistance or to the development of chronic diseases such as cancer. Toll-like receptors (TLRs) are innate immunity receptors that activate pro-inflammatory signaling pathways in response to intracellular damage or patterns associated with pathogens. The TLR4 receptor recognizes lipopolysaccharides, but is also related to the development of tumors. Our aim was to evaluate the Thr399Ile polymorphism of the TLR4 gene and its association with the risk of PCa occurrence. Twenty-nine patients with PCa and 22 with benign prostatic hyperplasia (BPH), genotyped by PCR-RFLP, were analyzed using the enzyme Hinf I. The genotypes found were normal homozygous-CC (16 with PCa and 11 with BPH), mutant homozygous-TT (10 with PCa and 10 with BPH) and heterorygous-CT (3 with PCa and 1 with BPH). However, in both groups, the genotypes were not in Hardy-Weinberg equilibrium. In addition, genotypic frequencies were not statistically different between individuals with PCa and BPH without correlation with clinical and anatomopathological data such as PSA (Prostatic-Specific Antigen), Gleason score and TNM. For the allelic distribution, the C allele was more frequent in patients with PCa, however without statistical significance. Studies with a larger number of participants and functional tests are needed to elucidate the role of this polymorphism in PCa.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-28T14:46:16Z
2020-12-28T14:46:16Z
2020-12-16
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bachelorThesis
format bachelorThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv REZENDE, Laura de Castro. Associação entre o polimorfismo Thr399Ile do gene TLR4 e a susceptibilidade ao câncer de próstata. 2020. 41f. Trabalho de Conclusão de Curso (Graduação em Biotecnologia) - Universidade Federal de Uberlândia, 2020.
https://repositorio.ufu.br/handle/123456789/30846
identifier_str_mv REZENDE, Laura de Castro. Associação entre o polimorfismo Thr399Ile do gene TLR4 e a susceptibilidade ao câncer de próstata. 2020. 41f. Trabalho de Conclusão de Curso (Graduação em Biotecnologia) - Universidade Federal de Uberlândia, 2020.
url https://repositorio.ufu.br/handle/123456789/30846
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Uberlândia
Brasil
Biotecnologia
publisher.none.fl_str_mv Universidade Federal de Uberlândia
Brasil
Biotecnologia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFU
instname:Universidade Federal de Uberlândia (UFU)
instacron:UFU
instname_str Universidade Federal de Uberlândia (UFU)
instacron_str UFU
institution UFU
reponame_str Repositório Institucional da UFU
collection Repositório Institucional da UFU
repository.name.fl_str_mv Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU)
repository.mail.fl_str_mv diinf@dirbi.ufu.br
_version_ 1805569652069236736